Medpace Holdings, Inc. (MEDP) stock
MEDPNasdaqServices-Commercial Physical & Biological ResearchFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 22, 2026Score 14/3042% above fair value
$653.09+4.89 (+0.75%)
Close on Nov 17, 2026Market cap $18.27BP/E 36.2Yield –
Medpace total assets
Total assets on the balance sheet at the end of each period.
Medpace's total assets was $2.30B at Sep 30, 2026. For fiscal 2025 it was $1.98B, down 6.0% from the year before. Over ten years it grew 7.2% a year on average. The highest annual figure on record is $2.10B in fiscal 2024.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.98B | -6.0% |
| FY2024 | Dec 31, 2024 | $2.10B | +26.8% |
| FY2023 | Dec 31, 2023 | $1.66B | +22.5% |
| FY2022 | Dec 31, 2022 | $1.35B | -18.5% |
| FY2021 | Dec 31, 2021 | $1.66B | +19.4% |
| FY2020 | Dec 31, 2020 | $1.39B | +21.7% |
| FY2019 | Dec 31, 2019 | $1.14B | +13.8% |
| FY2018 | Dec 31, 2018 | $1.00B | +5.7% |
| FY2017 | Dec 31, 2017 | $950.72M | -2.9% |
| FY2016 | Dec 31, 2016 | $979.11M | -0.5% |
| FY2015 | Dec 31, 2015 | $984.04M | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $2.30B | +31.4% |
| Q2 FY2026 | Jun 30, 2026 | $2.06B | +30.9% |
| Q1 FY2026 | Mar 31, 2026 | $2.13B | +12.2% |
| Q4 FY2025 | Dec 31, 2025 | $1.98B | -6.0% |
| Q3 FY2025 | Sep 30, 2025 | $1.75B | -15.9% |
| Q2 FY2025 | Jun 30, 2025 | $1.57B | -18.1% |
| Q1 FY2025 | Mar 31, 2025 | $1.90B | +5.7% |
| Q4 FY2024 | Dec 31, 2024 | $2.10B | +26.8% |
| Q3 FY2024 | Sep 30, 2024 | $2.08B | +40.2% |
| Q2 FY2024 | Jun 30, 2024 | $1.92B | +36.5% |
| Q1 FY2024 | Mar 31, 2024 | $1.80B | +28.7% |
| Q4 FY2023 | Dec 31, 2023 | $1.66B | +22.5% |
| Q3 FY2023 | Sep 30, 2023 | $1.49B | +11.9% |
| Q2 FY2023 | Jun 30, 2023 | $1.41B | +7.0% |
| Q1 FY2023 | Mar 31, 2023 | $1.40B | +3.8% |
| Q4 FY2022 | Dec 31, 2022 | $1.35B | -18.5% |
| Q3 FY2022 | Sep 30, 2022 | $1.33B | -15.8% |
| Q2 FY2022 | Jun 30, 2022 | $1.32B | -10.5% |
| Q1 FY2022 | Mar 31, 2022 | $1.34B | -7.4% |
| Q4 FY2021 | Dec 31, 2021 | $1.66B | +19.4% |
| Q3 FY2021 | Sep 30, 2021 | $1.58B | +21.7% |
| Q2 FY2021 | Jun 30, 2021 | $1.47B | +20.3% |
| Q1 FY2021 | Mar 31, 2021 | $1.45B | +27.6% |
| Q4 FY2020 | Dec 31, 2020 | $1.39B | +21.7% |
| Q3 FY2020 | Sep 30, 2020 | $1.30B | +20.9% |
| Q2 FY2020 | Jun 30, 2020 | $1.22B | +20.2% |
| Q1 FY2020 | Mar 31, 2020 | $1.14B | +13.0% |
| Q4 FY2019 | Dec 31, 2019 | $1.14B | +13.8% |
| Q3 FY2019 | Sep 30, 2019 | $1.07B | +12.9% |
| Q2 FY2019 | Jun 30, 2019 | $1.02B | +5.0% |
| Q1 FY2019 | Mar 31, 2019 | $1.01B | +3.4% |
| Q4 FY2018 | Dec 31, 2018 | $1.00B | +5.7% |
| Q3 FY2018 | Sep 30, 2018 | $949.84M | +0.1% |
| Q2 FY2018 | Jun 30, 2018 | $968.18M | +0.5% |
| Q1 FY2018 | Mar 31, 2018 | $973.02M | +0.7% |
| Q4 FY2017 | Dec 31, 2017 | $950.72M | -2.9% |
| Q3 FY2017 | Sep 30, 2017 | $948.88M | – |
| Q2 FY2017 | Jun 30, 2017 | $963.65M | – |
| Q1 FY2017 | Mar 31, 2017 | $966.09M | – |
| Q4 FY2016 | Dec 31, 2016 | $979.11M | – |
See a number that looks wrong?